Table 2.
IC50 Values of Different Liposome Formulations on αvβ6-Positive H2009 Cellsa
Drug Formulation | IC50 on H2009 cells (nM) |
---|---|
0.6% H2009.1 Tetrameric | 1500 ± 200 |
0.6% scH2009.1 Tetrameric | 2400 ± 120 |
0.6% Naked | 7400 ± 1400 |
| |
1.3% H2009.1 Monomeric | 5700 ± 120 |
1.3% H2009.1 Tetrameric | 970 ± 130 |
1.3% scH2009.1 Tetrameric | 2000 ± 330 |
1.3% Naked | Not reachedb |
| |
2.0% H2009.1 Tetrameric | 360 ± 35 |
2.0% scH2009.1 Tetrameric | 610 ± 90 |
2.0% Naked | 6900 ± 960 |
| |
Free Doxorubicin | 430 ± 75 |
Cells were incubated with liposomes for 1 hour followed by a 120 hour recovery in media.
Not reached at the highest treatment concentration of 10.2 μM.